Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.8.0.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Operating costs and expenses:    
Research and development $ (706,271) $ (1,221,144)
General and administrative (1,122,072) (1,634,533)
Loss from operations (1,828,343) (2,855,677)
Other income (expense):    
Other income (expense) 5,398 (9,356)
Interest income (expense) 427 (588)
Total other income (expense) 5,825 (9,944)
Net loss $ (1,822,518) $ (2,865,621)
Basic and diluted loss per share $ (0.21) $ (0.34)
Weighted-average shares of common stock outstanding, basic and diluted 8,717,541 8,518,830